Literature DB >> 31732320

Multifaceted Roles of TIM-Family Proteins in Virus-Host Interactions.

John P Evans1, Shan-Lu Liu2.   

Abstract

To enhance infection, enveloped viruses exploit adhesion molecules expressed on the surface of host cells. Specifically, phosphatidylserine (PS) receptors - including members of the human T cell immunoglobulin and mucin domain (TIM)-family - have gained attention for their ability to mediate the entry of many enveloped viruses. However, recent evidence that TIM-1 can restrict viral release reveals a new role for these PS receptors. Additionally, viral factors such as the HIV-1 accessory protein Nef can antagonize this antiviral activity of TIM-1 while host restriction factors such as SERINC5 can enhance it. In this review, we examine the various roles of PS receptors, specifically TIM-family proteins, and the intricate relationship between host and viral factors. Elucidating the multifunctional roles of PS receptors in virus-host interaction is important for understanding viral pathogenesis and developing novel antiviral therapeutics.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV; antagonism; phosphatidylserine receptor; viral entry; viral release

Mesh:

Substances:

Year:  2019        PMID: 31732320      PMCID: PMC7018592          DOI: 10.1016/j.tim.2019.10.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  89 in total

1.  Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein.

Authors:  Nadine Laguette; Nadia Rahm; Bijan Sobhian; Christine Chable-Bessia; Jan Münch; Joke Snoeck; Daniel Sauter; William M Switzer; Walid Heneine; Frank Kirchhoff; Frédéric Delsuc; Amalio Telenti; Monsef Benkirane
Journal:  Cell Host Microbe       Date:  2012-02-01       Impact factor: 21.023

2.  The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.

Authors:  Ben Murrell; Thomas Vollbrecht; John Guatelli; Joel O Wertheim
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

3.  HIV: a vicTIM.

Authors:  Jiri Vlach; Jamil S Saad
Journal:  Trends Microbiol       Date:  2014-10-16       Impact factor: 17.079

4.  Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells.

Authors:  Melissa K Callahan; Paul M Popernack; Shigeki Tsutsui; Linh Truong; Robert A Schlegel; Andrew J Henderson
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

5.  An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.

Authors:  Shilpi Sharma; Mary K Lewinski; John Guatelli
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

6.  Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.

Authors:  Silvia F Kluge; Katharina Mack; Shilpa S Iyer; François M Pujol; Anke Heigele; Gerald H Learn; Shariq M Usmani; Daniel Sauter; Simone Joas; Dominik Hotter; Frederic Bibollet-Ruche; Lindsey J Plenderleith; Martine Peeters; Matthias Geyer; Paul M Sharp; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

Review 7.  Tim-3 and its role in regulating anti-tumor immunity.

Authors:  Madhumita Das; Chen Zhu; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

8.  Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.

Authors:  Bethany A Rhein; Rachel B Brouillette; Grace A Schaack; John A Chiorini; Wendy Maury
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 9.  HIV Restriction Factors and Mechanisms of Evasion.

Authors:  Michael H Malim; Paul D Bieniasz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 10.  SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.

Authors:  Gracia Viviana Gonzalez-Enriquez; Martha Escoto-Delgadillo; Eduardo Vazquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  J Immunol Res       Date:  2017-11-22       Impact factor: 4.818

View more
  10 in total

Review 1.  Drugging the efferocytosis process: concepts and opportunities.

Authors:  Parul Mehrotra; Kodi S Ravichandran
Journal:  Nat Rev Drug Discov       Date:  2022-06-01       Impact factor: 112.288

2.  Phosphatidylethanolamine and Phosphatidylserine Synergize To Enhance GAS6/AXL-Mediated Virus Infection and Efferocytosis.

Authors:  Lizhou Zhang; Audrey S Richard; Cody B Jackson; Amrita Ojha; Hyeryun Choe
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 3.  Flagging fusion: Phosphatidylserine signaling in cell-cell fusion.

Authors:  Jarred M Whitlock; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2021-02-11       Impact factor: 5.157

Review 4.  Drug Repurposing Approaches to Combating Viral Infections.

Authors:  Jay Trivedi; Mahesh Mohan; Siddappa N Byrareddy
Journal:  J Clin Med       Date:  2020-11-23       Impact factor: 4.241

5.  Scrambled or flipped: 5 facts about how cellular phosphatidylserine localization can mediate viral replication.

Authors:  Marissa Danielle Acciani; Melinda Ann Brindley
Journal:  PLoS Pathog       Date:  2022-03-04       Impact factor: 6.823

Review 6.  The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection.

Authors:  Shaofen Xu; Zhichao Zheng; Janak L Pathak; Haoyu Cheng; Ziliang Zhou; Yanping Chen; Qiuyu Wu; Lijing Wang; Mingtao Zeng; Lihong Wu
Journal:  Front Cell Dev Biol       Date:  2022-04-01

7.  A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer.

Authors:  Sheng Liu; Wenting Tang; Jing Cao; Mei Shang; Hengchang Sun; Jiao Gong; Bo Hu
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 8.  Targeting phosphatidylserine for Cancer therapy: prospects and challenges.

Authors:  Wenguang Chang; Hongge Fa; Dandan Xiao; Jianxun Wang
Journal:  Theranostics       Date:  2020-07-23       Impact factor: 11.556

9.  Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5.

Authors:  Steven W Jin; Francis M Mwimanzi; Jaclyn K Mann; Mwebesa Bosco Bwana; Guinevere Q Lee; Chanson J Brumme; Peter W Hunt; Jeff N Martin; David R Bangsberg; Thumbi Ndung'u; Zabrina L Brumme; Mark A Brockman
Journal:  PLoS Pathog       Date:  2020-09-14       Impact factor: 6.823

Review 10.  Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review).

Authors:  Т А Karmakova; N S Sergeeva; К Yu Kanukoev; B Ya Alekseev; А D Kaprin
Journal:  Sovrem Tekhnologii Med       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.